NURS 6501 Exam 2 | UPDATED Questions with 100% Verified
Answers
Walden University • NURS 6501
Q1: Clinical Presentation of Acute Bronchitis
A: cough (productive or not) is most likely but fever, muscle aches, and fatigue can also be present. Burning substernal
pain with breathing in. Cough lasts longer than 7 days but shouldn't last more than 3 weeks.
Q2: Best Treatment Viral Bronchitis
A: most people improve on their own antitussives like dextromethorphan or benzonatate helps short term codeine or
hydrocodone if cough is severe antipyretics, bed rest and increased fluid consuption
Q3: classic signs of asthma
A: intermittent dyspnea, wheezing, coughing (worse at night), SOB, chest tightness. Hx or presence of respiratory sx
AND demonstrated variable expiratory airflow obstruction. Inflammation and bronchial hyper-responsiveness. PE:
wheezing, eachypnea, tachycardia, prolonged expiratory phase of respiration, pale/swollen nasal membranes,
cobblestone pharyngeal wall, cough, nasal polyps.
Q4: Asthma Triggers
A: tobacco smoke, beta blockers, aspirin, and NSAIDs URI are #1 molds, pollen, dust mites, cockroaches, and animal
danger
Q5: best diagnostic test for asthma
A: FEV1 (spirometry) mild is 80% or more moderate is 60-80 severe is less than 60
Q6: Rule of 2 for asthma
A: symptoms requiring SABA more than twice a week nocturnal symptoms more than twice per month refill of quick
relief inhaler more than two times per year
Q7: mild asthma
A: Symptoms <2x/week, FEV1 >80% of best
, Q8: moderate asthma
A: Symptoms >2x/week, FEV1 >60-80%
Q9: severe asthma
A: Continuous symptoms, FEV1<60%, frequent nocturnal symptoms, hospitalizations
Q10: stepwise treatment of asthma
A: intermittent: SABA mild persistent: low dose ICS or leukotriene modifier moderate persistent: low dose ICS + LABA,
med ICS, LAMA +ICS severe persistent: med or high ICS + LABA (may add leukotriene modifier, tiotripium, biologic
agent)
Q11: black box warning for asthma treatment
A: must prescribe ICS with LABA, never a LABA alone
Q12: criteria for diagnosing asthma with pulmonary function test results
A: variability testing before and after bronchodilator, from one office visit to another or before after bronchoprovocation
challenge. Increase FEV of 12% or more, accompanied by an absolute increase in FEV1 of at least 200 mL
Q13: hemoptysis
A: coughing up blood
Q14: hematemesis
A: vomiting blood
Q15: epistaxis
A: nosebleed
Q16: pleural effusion
A: abnormal amount of fluid within the pleural space. The pleura is a serous membrane covering the lung parenchyma,
mediastinum, diaphragm and rib cage. Two pleural membranes: parietal (lines chest cavity) and visceral (covers both
lungs). Occurs when fluid formation exceeds fluid absorption. CHF is one of most common causes.
Answers
Walden University • NURS 6501
Q1: Clinical Presentation of Acute Bronchitis
A: cough (productive or not) is most likely but fever, muscle aches, and fatigue can also be present. Burning substernal
pain with breathing in. Cough lasts longer than 7 days but shouldn't last more than 3 weeks.
Q2: Best Treatment Viral Bronchitis
A: most people improve on their own antitussives like dextromethorphan or benzonatate helps short term codeine or
hydrocodone if cough is severe antipyretics, bed rest and increased fluid consuption
Q3: classic signs of asthma
A: intermittent dyspnea, wheezing, coughing (worse at night), SOB, chest tightness. Hx or presence of respiratory sx
AND demonstrated variable expiratory airflow obstruction. Inflammation and bronchial hyper-responsiveness. PE:
wheezing, eachypnea, tachycardia, prolonged expiratory phase of respiration, pale/swollen nasal membranes,
cobblestone pharyngeal wall, cough, nasal polyps.
Q4: Asthma Triggers
A: tobacco smoke, beta blockers, aspirin, and NSAIDs URI are #1 molds, pollen, dust mites, cockroaches, and animal
danger
Q5: best diagnostic test for asthma
A: FEV1 (spirometry) mild is 80% or more moderate is 60-80 severe is less than 60
Q6: Rule of 2 for asthma
A: symptoms requiring SABA more than twice a week nocturnal symptoms more than twice per month refill of quick
relief inhaler more than two times per year
Q7: mild asthma
A: Symptoms <2x/week, FEV1 >80% of best
, Q8: moderate asthma
A: Symptoms >2x/week, FEV1 >60-80%
Q9: severe asthma
A: Continuous symptoms, FEV1<60%, frequent nocturnal symptoms, hospitalizations
Q10: stepwise treatment of asthma
A: intermittent: SABA mild persistent: low dose ICS or leukotriene modifier moderate persistent: low dose ICS + LABA,
med ICS, LAMA +ICS severe persistent: med or high ICS + LABA (may add leukotriene modifier, tiotripium, biologic
agent)
Q11: black box warning for asthma treatment
A: must prescribe ICS with LABA, never a LABA alone
Q12: criteria for diagnosing asthma with pulmonary function test results
A: variability testing before and after bronchodilator, from one office visit to another or before after bronchoprovocation
challenge. Increase FEV of 12% or more, accompanied by an absolute increase in FEV1 of at least 200 mL
Q13: hemoptysis
A: coughing up blood
Q14: hematemesis
A: vomiting blood
Q15: epistaxis
A: nosebleed
Q16: pleural effusion
A: abnormal amount of fluid within the pleural space. The pleura is a serous membrane covering the lung parenchyma,
mediastinum, diaphragm and rib cage. Two pleural membranes: parietal (lines chest cavity) and visceral (covers both
lungs). Occurs when fluid formation exceeds fluid absorption. CHF is one of most common causes.
